Probable rofecoxib-induced thrombocytopenia

Rheumatology (Oxford). 2003 May;42(5):699-700. doi: 10.1093/rheumatology/keg155.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Lactones / adverse effects*
  • Male
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases
  • Sulfones
  • Thrombocytopenia / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lactones
  • Membrane Proteins
  • Sulfones
  • rofecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases